Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Inquiry Memorial
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Support and FAQs
    • NHS Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Hepatitis C Testing
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

A review of previous reports of post-transfusion hepatitis began with the words: "It must now be recognised that under certain circumstances at present undefined hepatic necrosis may follow the parenteral administration of human blood products."

Published on: 06 August, 2024

In a note from Dr Panton to Dr Bradley, a joint sub-committee of the Jaundice Committee and the Blood Transfusion Research Committee of the Medical Research Council was proposed to deal specifically with post-transfusion hepatitis.

Published on: 06 August, 2024

The meeting of the Jaundice Committee showed that post-transfusion or serum hepatitis was well recognised by 1944.

Published on: 06 August, 2024

Bradley et al, in their article 'An Episode of 'Homologous Serum Jaundice' in The British Medical Journal, noted that the risk of transfusion-related hepatitis was sufficiently serious to set up a sub-committee in 1945 dealing solely with post-transfusion hepatitis.

Published on: 06 August, 2024

In a letter from Dr Maycock to Dr Robb-Smith, it was noted that users of plasma must be told that it was a potentially lethal fluid which should be used with discretion.

Published on: 06 August, 2024

In a note from Dr Maycock to Miss Long, the need to tell patients that they were at risk of contracting hepatitis via transfusion was noted.

Published on: 06 August, 2024

In a letter from J H Keidan Solicitors to Miss Long, the need to tell patients they were at risk was advised by solicitors.

Published on: 06 August, 2024

It was noted in MacCallum's Homologous Serum Hepatitis Proceedings of the Royal Society of Medicine that pooling plasma from a larger pool of donors would increase the risk of contracting hepatitis.

Published on: 06 August, 2024

Dr Maycock was concerned that a legal case regarding a lady that had died from hepatitis-related transfusion would lead to the plasma production being stopped.

Published on: 06 August, 2024

Dr Maycock did not believe there would be a strong case against the Blood Transfusion Service regarding a case involving hepatitis related transfusion, however was concerned that if litigation did take place, it could shut off the supply of plasma.

Published on: 06 August, 2024

The post-mortem of a woman affected by transfusion-related jaundice returned a verdict of misadventure.

Published on: 06 August, 2024

Large pool plasma filtration was abandoned due to the prevalence of homologous serum jaundice.

Published on: 17 October, 2024

By 1975, two years after Hepatitis A was identified, there was a test for both Hepatitis A and Hepatitis B.

Published on: 06 August, 2024

US studies showed that serum hepatitis caused death at a rate of approximately 1 in every 150 transfusions in the US in people over the age of 40. US Studies showed the mortality rate in late middle age of those infected could be as high as 40%.

Published on: 06 August, 2024

Update on the expert groups ahead of the preliminary hearings

Published on: 11 June, 2020

Inquiry publishes report by the Statistics Expert Group

Published on: 24 August, 2023

Further instruction letter to Psychosocial expert group published

Published on: 27 September, 2022

"The Sunday Telegraph" reported that a post-mortem carried out on a man with haemophilia found the vCJD prion in his spleen, which prompted an update being urgently sent to people with bleeding disorders.

Published on: 29 July, 2024

The chief medical officers of each of the four nations responded to a request to approve the framework for the management of possible exposures to CJD through medical procedures.

Published on: 29 July, 2024

A fourth case of vCJD transmission was associated with blood transfusion and was reported to the press.

Published on: 03 October, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2149
  • Page 2150
  • Page 2151
  • Page 2152
  • Current page 2153
  • Page 2154
  • Page 2155
  • Page 2156
  • Page 2157
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.